Loading
·
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.
The quarterly reports for this company are not available yet. Please check back later.
In the mean time, check out some related stocks.